Clinical feasibility of ultra-rapid, non-pharmacologic anesthesia for intravitreal injection in patients receiving anti-VEGF treatment

被引：0
|
作者：
Besirli, Cagri G. [1 ]
Smith, Stephen [2 ]
Pipe, Kevin [3 ]
Kim, Gunho [3 ]
Zacks, David N. [1 ]
Gardner, Thomas W. [1 ]
Shah, Anjali [1 ]
机构：
[1] Univ Michigan, Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA
[2] Stanford Univ, Ophthalmol, Palo Alto, CA 94304 USA
[3] Univ Michigan, Mech Engn, Ann Arbor, MI 48109 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1618
引用
收藏
页数：3
相关论文
共 50 条
  • [21] A CLINICAL CASE STUDY - EMERGENCE OF MONOCULAR SHORTSIGHTEDNESS AFTER INTRAVITREAL INJECTION OF ANTI-VEGF DRUGS
    Lv, W. J.
    Fan, Y. B.
    Xiao, Y.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 : 33 - 33
  • [22] Use of Artificial Tears in Patients Undergoing Treatment with Anti-VEGF Intravitreal Injections
    Pastor-Pascual, Francisco
    Pastor-Pascual, Rafael
    Galvez-Perez, Patricia
    Dolz-Marco, Rosa
    Gallego-Pinazo, Roberto
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 3959 - 3972
  • [23] The effect of non-pharmacologic treatment on clinical status of patients with heart failure
    Vaquero, N.
    Gonzalez, D. G.
    Castillo, L.
    Orea, A.
    Bernal, M. F.
    Lozadal, M.
    Kauffman, E.
    Lozano, O.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 297 - 298
  • [24] Efficacy of Photodynamic Therapy With or Without Intravitreal Anti-VEGF Injection for the Treatment of Polypoidal Choroidal Vasculopathy
    Yu, H.
    Kim, S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [25] Prophylaxis with intraocular pressure lowering medication and glaucomatous progression in patients receiving intravitreal anti-VEGF therapy
    Du, Jeanette
    Patrie, James T.
    Cai, Xiao-Yu
    Prum, Bruce E.
    Shildkrot, Yevgeniy
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2022, 15 (10) : 1611 - 1618
  • [26] Defining predictors of Vision-related Quality of Life in Patients with Exudative Retinal Diseases receiving Intravitreal anti-VEGF Treatment
    Rausch-Koster, T. P.
    Rennert, K. N.
    Verbraak, F. D.
    van Rens, G. H. M. B.
    van Nispen, R. M. A.
    ACTA OPHTHALMOLOGICA, 2021, 99 : 17 - 17
  • [27] Prophylaxis with intraocular pressure lowering medication and glaucomatous progression in patients receiving intravitreal anti-VEGF therapy
    Jeanette Du
    James T Patrie
    Xiao-Yu Cai
    Bruce E Prum
    Yevgeniy Shildkrot
    International Journal of Ophthalmology, 2022, 15 (10) : 1611 - 1618
  • [28] RETRACTED: Clinical Study of Intravitreal Injection of Anti-VEGF Drugs Combined with Triamcinolone Acetonide in the Treatment of Coats Disease (Retracted Article)
    Wu, ShaoFeng
    Fang, Jing
    Yu, Fang
    Han, Fang
    Xiao, Jun
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
  • [29] Clinical impact of COVID-19 on patients with choroidal neovascularization on intravitreal anti-VEGF therapy
    Agorogiannis, Eleftherios I.
    Maleedy, Deena
    Hakim, Navid
    McDaid, David
    Silver, Laura
    Madhusudhan, Savita
    Beare, Nicholas A. V.
    EYE, 2022, 36 (05) : 1113 - 1114
  • [30] Clinical impact of COVID-19 on patients with choroidal neovascularization on intravitreal anti-VEGF therapy
    Eleftherios I. Agorogiannis
    Deena Maleedy
    Navid Hakim
    David McDaid
    Laura Silver
    Savita Madhusudhan
    Nicholas A. V. Beare
    Eye, 2022, 36 : 1113 - 1114
12345